Cargando…
High‐dose atorvastatin improves vascular endothelial function in patients with leukoaraiosis
OBJECTIVE: Leukoaraiosis (LA), as an age‐related white matter degeneration, is mainly caused by chronic ischemia. Our study aims to explore the efficacy of different doses of atorvastatin (ATV) in the vascular endothelial function in patients with LA. METHODS: Our study enrolled 402 LA patients who...
Autores principales: | Xue, Jianan, Wu, Zhisheng, Gong, Shujie, Qin, Shengying, Gu, Aiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083452/ https://www.ncbi.nlm.nih.gov/pubmed/32154613 http://dx.doi.org/10.1002/jcla.23081 |
Ejemplares similares
-
A DTI study of leukoaraiosis and the differential diagnosis between leukoaraiosis and acute lacunar infarction
por: Zhao, De‐Qiang, et al.
Publicado: (2019) -
Atorvastatin and sildenafil lower blood pressure and improve endothelial dysfunction, but only atorvastatin increases vascular stores of nitric oxide in hypertension()
por: Guimarães, Danielle A., et al.
Publicado: (2013) -
The association of uric acid with leukoaraiosis
por: Li, Jun-Jing, et al.
Publicado: (2016) -
Pathogenesis and research progress in leukoaraiosis
por: Sun, Lingqi, et al.
Publicado: (2022) -
Atorvastatin combined with low-dose dexamethasone for vascular endothelial cell dysfunction induced by chronic subdural hematoma
por: Fan, Yue-Shan, et al.
Publicado: (2020)